Clinical Trial Update: Predictors of Adherence to Orencia

View source ↗

Summary

This clinical trial update reports on factors predicting adherence to abatacept (Orencia) in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED